Valuation: ViaDerma, Inc.

Market Cap 6.31M 5.46M 5.12M 4.67M 8.78M 601M 8.91M 60.2M 23.53M 301M 23.68M 23.16M 1B P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 6.6M 5.72M 5.36M 4.89M 9.19M 630M 9.33M 63.04M 24.64M 315M 24.79M 24.25M 1.05B EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
Manager TitleAgeSince
Chief Executive Officer - 30/03/2014
Director TitleAgeSince
Chairman - 30/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+5.85%-24.07% - - 247K
-1.60%+0.86%+3.70%+14.41% 48.72B
-0.14%+4.03%+482.13%+584.43% 43.99B
-0.06%+9.62%+24.63%+81.63% 40.82B
-0.87%+2.40%+30.01%+9.95% 39.79B
-4.04%+6.15%+23.03%+48.00% 32.7B
-1.41%+1.57%+29.98%+123.68% 16.66B
+0.35%+4.61% - - 16.84B
-0.43%-0.11%+4.22%+20.83% 13.95B
+0.84%+9.07%+86.17%+32.60% 13.58B
Average -0.15%+3.96%+85.48%+114.44% 29.67B
Weighted average by Cap. -0.99%+3.93%+104.21%+137.91%

Financials

2015 2016
Net sales 192K 166K 156K 142K 267K 18.29M 271K 1.83M 716K 9.16M 720K 704K 30.54M 252K 218K 205K 187K 351K 24.03M 356K 2.41M 940K 12.03M 946K 926K 40.13M
Net income 27.12K 23.5K 22.02K 20.08K 37.75K 2.59M 38.33K 259K 101K 1.3M 102K 99.62K 4.32M -122K -106K -98.88K -90.19K -170K -11.62M -172K -1.16M -455K -5.82M -457K -447K -19.4M
Net Debt 288K 250K 234K 213K 401K 27.49M 407K 2.75M 1.08M 13.77M 1.08M 1.06M 45.9M 297K 257K 241K 220K 413K 28.31M 419K 2.83M 1.11M 14.17M 1.11M 1.09M 47.26M
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
-